More Diverse Clinical Trials Can Lead to Improved Outcomes in Lupus

Published: Dec. 10, 2018, 1:50 p.m.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.